BRAF and melanoma: Amblyomin-X sensitive human melanoma cells have mutant BRAF gene that increases kinase activity of BRAF, leading to constitutive activation of the RAS-RAF-MEK-ERK pathway and thus uncontrolled tumor proliferation [39, 40].